Researchers with the U.S. Department of Energy (DOE)’s Lawrence Berkeley National Laboratory (Berkeley Lab) have found new evidence to explain how cholesteryl ester transfer protein (CETP) mediates the transfer of cholesterol from “good” high density l…
Scientists from the University of Leicester and the University of California Los Angeles (UCLA) have announced a major advance towards developing drugs to tackle dangerous, or ‘bad’, cholesterol in the body. They have filed two patents for developing t…
The US Food and Drug Administration (FDA) announced on Wednesday that it has approved the first generic version of the world’s top-selling medicine, the cholesterol-lowering drug Lipitor (atorvastatin), currently marketed by Pfizer Inc. Ranbaxy Labo…
Adding high doses of extended-release niacin to reduce improve cholesterol levels will not reduce heart attack or stroke risk for patients with stable, chronic heart disease whose LDL cholesterol is well controlled, researchers reported in NEJM (New En…
High LDL, or bad cholesterol levels increase the risk of developing cardiovascular diseases, especially in those with high LDL levels and low levels of HDL (good cholesterol). At the American Heart Association’s Scientific Sessions 2011 researchers pr…
A study presented at the American Heart Association Scientific sessions shows that the use of the medication evacetrapib alone or in conjunction with statin drugs was linked to a considerable increase in high-density lipoprotein cholesterol (HDL-C) and…
Patients unable to control their cholesterol levels with medications may someday be able to lower their “bad” cholesterol with a shot, according to research presented at the American Heart Association’s Scientific Sessions 2011. In its first preliminar…
A new study published online in the European Journal of Clinical Nutrition shows that soy protein compared to dairy milk protein supplementation improves the lipid profile in healthy individuals. This study investigated the effect of soy and milk prote…
Spherix Incorporated (NASDAQ: SPEX) an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical compa…
New research demonstrates that a diet based around plants, nuts and high-fiber grains lowered “bad” cholesterol more than a low-saturated-fat diet that was also vegetarian, meaning that one’s dietary changes could be an alternative to statin medication…
